[ CAS No. 10083-24-6 ] {[proInfo.proName]}

Name: 10083-24-6|(E)-4-(3,5-Dihydroxystyryl)benzene-1,2-diol|98%
Brand: Ambeed
SKU: A162917
Price: 5.0 USD
Availability: InStock
Rating: 94 (27 reviews)

,{[proInfo.pro_purity]}

Cat. No.: {[proInfo.prAm]}

DV 2D 3D

3d Animation Molecule Structure of 10083-24-6

Structure of 10083-24-6 * Storage: {[proInfo.prStorage]}

Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Search after Editing

* Storage: {[proInfo.prStorage]}

For Research Only 110K+ Compounds Competitive Price 1-2 Day Shipping

Quality Control of [ 10083-24-6 ]

COA NMR CNMR HPLC LC-MS

Related Doc. of [ 10083-24-6 ]

SDS Specification

Alternatived Products of [ 10083-24-6 ]

Product Details of [ 10083-24-6 ]

CAS No. :	10083-24-6	MDL No. :	MFCD00221715
Formula :	C₁₄H₁₂O₄	Boiling Point :	-
Linear Structure Formula :	-	InChI Key :	-
M.W :	244.24	Pubchem ID :	-
Synonyms :	Astringenin;trans-Piceatannol;NSC 622471;trans-3,3',4,5'-Tetrahydroxystilbene;trans-Picetannol	Chemical Name :	(E)-4-(3,5-Dihydroxystyryl)benzene-1,2-diol

Calculated chemistry of [ 10083-24-6 ]

Physicochemical Properties

Num. heavy atoms :	18
Num. arom. heavy atoms :	12
Fraction Csp3 :	0.0
Num. rotatable bonds :	2
Num. H-bond acceptors :	4.0
Num. H-bond donors :	4.0
Molar Refractivity :	69.9
TPSA :	80.92 Å²

Pharmacokinetics

GI absorption :	High
BBB permeant :	No
P-gp substrate :	No
CYP1A2 inhibitor :	Yes
CYP2C19 inhibitor :	No
CYP2C9 inhibitor :	Yes
CYP2D6 inhibitor :	No
CYP3A4 inhibitor :	Yes
Log Kp (skin permeation) :	-5.76 cm/s

Lipophilicity

Log Po/w (iLOGP) :	1.61
Log Po/w (XLOGP3) :	2.86
Log Po/w (WLOGP) :	2.46
Log Po/w (MLOGP) :	1.67
Log Po/w (SILICOS-IT) :	2.08
Consensus Log Po/w :	2.14

Druglikeness

Lipinski :	0.0
Ghose :	None
Veber :	0.0
Egan :	0.0
Muegge :	0.0
Bioavailability Score :	0.55

Water Solubility

Log S (ESOL) :	-3.52
Solubility :	0.0742 mg/ml ; 0.000304 mol/l
Class :	Soluble
Log S (Ali) :	-4.22
Solubility :	0.0148 mg/ml ; 0.0000605 mol/l
Class :	Moderately soluble
Log S (SILICOS-IT) :	-2.71
Solubility :	0.475 mg/ml ; 0.00195 mol/l
Class :	Soluble

Medicinal Chemistry

PAINS :	1.0 alert
Brenk :	2.0 alert
Leadlikeness :	1.0
Synthetic accessibility :	2.09

Safety of [ 10083-24-6 ]

Signal Word:	Warning	Class:	N/A
Precautionary Statements:	P261-P305+P351+P338	UN#:	N/A
Hazard Statements:	H315-H319-H335	Packing Group:	N/A
GHS Pictogram:

Application In Synthesis of [ 10083-24-6 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

Upstream synthesis route of [ 10083-24-6 ]
Downstream synthetic route of [ 10083-24-6 ]

[ 10083-24-6 ] Synthesis Path-Upstream 1~1

1
[ 501-36-0 ]
[ 10083-24-6 ]
[ 26153-38-8 ]
[ 99-10-5 ]
[ 123-08-0 ]

Reference： [1] Rapid Communications in Mass Spectrometry, 2010, vol. 24, # 5, p. 634 - 642
[2] Biochimie, 2012, vol. 94, # 3, p. 741 - 747

[ 10083-24-6 ] Synthesis Path-Downstream 1~73

1
[ 186581-53-3 ]
[ 113725-62-5 ]
[ 10083-24-6 ]
[ 87826-68-4 ]

Reference： [1]Journal of the Chemical Society. Perkin transactions I,1987,p. 1705 - 1712

2
[ 186581-53-3 ]
[ 10083-24-6 ]
[ 113681-39-3 ]
[ 113681-37-1 ]

Reference： [1]Journal of the Chemical Society. Perkin transactions I,1987,p. 1705 - 1712
[2]Journal of the Chemical Society. Perkin transactions I,1987,p. 1705 - 1712

3
[ 186581-53-3 ]
[ 113725-62-5 ]
[ 10083-24-6 ]
[ 108-24-7 ]
[ 87826-70-8 ]

Reference： [1]Journal of the Chemical Society. Perkin transactions I,1987,p. 1705 - 1712

4
[ 186581-53-3 ]
[ 10083-24-6 ]
[ 108-24-7 ]
[ 87826-65-1 ]
[ 87826-68-4 ]

Reference： [1]Journal of the Chemical Society. Perkin transactions I,1987,p. 1705 - 1712

5
[ 29884-49-9 ]
[ 2280-44-6 ]
[ 10083-24-6 ]

Reference： [1]Chemical and pharmaceutical bulletin,1984,vol. 32,p. 3501 - 3517

6
[ 10083-24-6 ]
[ 22318-80-5 ]

Yield	Reaction Conditions	Operation in experiment
	With palladium 10% on activated carbon; hydrogen; In ethanol; for 3h;	General procedure: Dihydro derivatives of compounds 7, 9, 11, 13, 15, 17, 19, 21, and 23 were prepared by hydrogenation of corresponding stilbenes. A standard protocol was followed,32 with minor modifications. Solutions of each stilbene (10mg) in absolute EtOH (5ml) were stirred under H2 for 3h in the presence of 10% Pd/C. The reaction mixtures were filtered over Celite to remove the catalyst, and evaporated to dryness. The resulting residues were purified by flash column chromatography, using a hexane/EtOAc gradient, to afford target compounds 8, 10, 12, 14, 16, 18, 20, 22, and 24, respectively, in yields of 85-95%. The spectroscopic data of compounds were in agreement with the literature, except for compound 24, for which no report was found (1H NMR spectrum is provided as Supporting information).32-41

Reference： [1]Chemical and Pharmaceutical Bulletin,1991,vol. 39,p. 3276 - 3278
[2]Bioorganic and Medicinal Chemistry,2001,vol. 9,p. 41 - 50
[3]Bioorganic and Medicinal Chemistry,2014,vol. 22,p. 1276 - 1284

7
[ 10586-13-7 ]
[ 29680-76-0 ]
[ 10083-24-6 ]

Reference： [1]Journal of the Chemical Society. Perkin transactions I,1987,p. 1705 - 1712

8
[ 116181-54-5 ]
[ 2280-44-6 ]
[ 10083-24-6 ]

Reference： [1]Chemical and pharmaceutical bulletin,1988,vol. 36,p. 1545 - 1549

9
[ 94356-26-0 ]
[ 2280-44-6 ]
[ 10083-24-6 ]

Reference： [1]Chemical and pharmaceutical bulletin,1984,vol. 32,p. 3501 - 3517

10
[ 10083-24-6 ]
[ 67-64-1 ]
[ 90275-02-8 ]

Reference： [1]Chemical and Pharmaceutical Bulletin,1985,vol. 33,p. 2904 - 2909
[2]Chemical and Pharmaceutical Bulletin,1984,vol. 32,p. 801 - 804

11
[ 150258-78-9 ]
[ 10083-24-6 ]

Yield	Reaction Conditions	Operation in experiment
89%	With hydrogen; In dichloromethane; at 20℃; under 3750.38 Torr; for 5h;	3, 3 ', 4', 5-tetrabenzyloxyphenyl stilbene 30.4g,Was dissolved in 240 mL of CH2C12,Then, 22 g of a catalyst having a Pd loading of 5% was added,0.5MPa pressure into the hydrogen,The reaction was carried out at room temperature for 5 h. After the reaction was completed, the catalyst RS001 was recovered by filtration and the filtrate was steamed to recover the reaction solvent to obtain crude product. The crude product was recrystallized from ethanol,to give 10.9g of picestannol and the yield was 89%.
79%	With phosphorus tribromide; In dichloromethane; cyclohexane; at 0℃; for 2h;	To a solution of compound 16 (0.0012 mol) in CH2Cl2 (20 mL), a mixture of BBr3 and cyclohexane (5 mL, 1:1) was added, and stirred at 0 C for 2 h. Ice water was added to the reaction solution and solution was extracted with ethyl acetate. The organic layer was washed with water and brine, dried over anhydrous magnesium sulfate, and evaporated. The crude product was purified by silica-gel chromatography using CHCl3/MeOH 10:1 as an eluent to give piceatannol (1) (0.0098 mol, 79.0%). ESI-MS: [M-H]- 242.9; 1H NMR (acetone-d6, 300 MHz) delta: 7.42 (1H, d, J = 8.1 Hz), 7.04 (1H, br s), 6.99-6.82 (3H, m), 6.55 (2H, br s), 6.36 (1H, br s) HPLC analysis 97.6% (MeOH: H2O = 55: 45 (V/V), tR = 11.33 min).
75%	With palladium 10% on activated carbon; ammonium formate; In methanol; 1,2-dichloro-ethane; at 40℃; for 1.08333h;	Weighing 0 . 10 g of formula II - 5 shown (E)-1-(3,4-dibenzyloxyphenyl)-2-(3,5-dibenzyloxyphenyl)ethylene and 0 . 078 g ammonium formate in 3 ml mixed solvent (1, 2 - dichloroethane/methanol=1/2) in heating to 40 C, stirring 15 minutes, the raw material is dissolved. The insulation by adding 0 . 018 g 10% palladium-carbon catalyst, thermal insulation stirring TLC monitoring until the reaction is complete, about 50 minutes. Filtering to remove the palladium-carbon, reducing pressure of the mother liquor solvent, residue by column chromatography separation to obtain the target product I - 5 indicated by the 5-[(1E)-2-(3,4-dihydroxyphenyl)vinyl]-1,3-benzenediol 0.030g, yield 75%.

32%

With boron tribromide; ascorbic acid; In dichloromethane; at -20 - 20℃; for 3h;

To a solution of compound 13 (0.079 g, 0.13 mmol) and ascorbic acid (0.002 g, 0.01 mmol) as catalyst in anhydrous CH2Cl2 (2 mL) was added BBr3 (1.0 M solution in CH2Cl2, 0.52 mmol)At -20 [deg.] C and stirred at this temperature for one hour. The reaction mixture was allowed to warm to room temperature and stirred for two hours. After completion of the reaction, the reaction mixture was cooled to 0 deg. C and H2O (2 mL) was slowly added thereto. The mixture was extracted with EtOAc (2 x 20 mL). The combined organic solvent layers were washed with brine (2 x 10 mL), dried over anhydrous Na2SO4 and concentrated in vacuo. The crude compound was purified by column chromatography (CH2Cl2: MeOH = 10: 1) to give purified compound 2 (0.01 g, 32%) which was a pale yellow solid

Reference： [1]Patent: CN106995364,2017,A .Location in patent: Paragraph 0036; 0037
[2]Bioorganic and Medicinal Chemistry,2011,vol. 19,p. 5085 - 5092
[3]Patent: CN106336347,2017,A .Location in patent: Paragraph 0079-0080
[4]Journal of Medicinal Chemistry,1993,vol. 36,p. 2950 - 2955
[5]Patent: KR2017/97422,2017,A .Location in patent: Paragraph 0023; 0034; 0035

12
[ 10586-13-7 ]
(3,5-dihydroxybenzyl)triphenylphosphonium bromide [ No CAS ]
[ 10083-24-6 ]

Reference： [1]Justus Liebigs Annalen der Chemie,1971,vol. 750,p. 109 - 127

13
[ 83088-26-0 ]
[ 10083-24-6 ]

Yield	Reaction Conditions	Operation in experiment
		4.5 ml of chlorobenzene and 15.7 g of triethylamine (155.1 mmol; 21 mol. eq.) are introduced into a three-necked round-bottomed flask. A nitrogen atmosphere is applied, the mixture is cooled to 0-50C and 12.8 g of anhydrous aluminium chloride (95 mmol; 13 mol. eq.) are added in 30 min. The medium is brought to 60C for 1 h. 2.2 g of tetramethylpiceatannol (7.3 mmol) dissolved in 4.5 ml of chlorobenzene are introduced at this temperature over 1 h and the reaction medium is maintained at this temperature for 4 h and then at 80C for 4 h. It is brought back to ambient temperature, separation by settling is carried out and the heavy phase is recovered and hydrolysed by running dropwise onto 40 g of a 50/50 water/ice mixture. The mixture is kept stirred at this temperature for 1 h 30. The medium is extracted with 4 times 25 ml of methyl ethyl ketone and the organic phase is washed with a saturated sodium bicarbonate solution and then with water. 1.62 g of crude (E)-piceatannol are recovered in the form of a brown solid.The product is purified from a 5/95 mixture of methanol/water in order to result in piceatannol exhibiting a melting point of 233-34C. <n="13"/>The proton and 13C NMR spectra are in agreement with the structure of (E)- piceatannol.

Reference： [1]Bioorganic and Medicinal Chemistry,2004,vol. 12,p. 5571 - 5578
[2]Journal of Organic Chemistry,1997,vol. 62,p. 417 - 421
[3]Journal of Agricultural and Food Chemistry,1999,vol. 47,p. 3974 - 3977
[4]Patent: WO2009/43761,2009,A1 .Location in patent: Page/Page column 10

14
[ 10083-24-6 ]
[ 20675-96-1 ]
(+/-)-5-[(1E)-2-[(2R,3R)-2,3-dihydro-3-(4-hydroxy-3,5-dimethoxyphenyl)-2-(hydroxymethyl)-1,4-benzodioxin-7-yl]ethenyl]benzene-1,3-diol [ No CAS ]
(+/-)-5-[(1E)-2-[(2R,3S)-2,3-dihydro-3-(4-hydroxy-3,5-dimethoxyphenyl)-2-(hydroxymethyl)-1,4-benzodioxin-7-yl]ethenyl]benzene-1,3-diol [ No CAS ]
(+/-)-5-[(1E)-2-[(2S,3S)-2,3-dihydro-3-(4-hydroxy-3,5-dimethoxyphenyl)-2-(hydroxymethyl)-1,4-benzodioxin-6-yl]ethenyl]benzene-1,3-diol [ No CAS ]
(+/-)-5-[(1E)-2-[(2R,3S)-2,3-dihydro-3-(4-hydroxy-3,5-dimethoxyphenyl)-2-(hydroxymethyl)-1,4-benzodioxin-6-yl]ethenyl]benzene-1,3-diol [ No CAS ]

Reference： [1]Organic and biomolecular chemistry,2003,vol. 1,p. 2427 - 2429
[2]Australian Journal of Chemistry,2007,vol. 60,p. 243 - 250

15
[ 1018449-53-0 ]
[ 10083-24-6 ]

Reference： [1]Australian Journal of Chemistry,2007,vol. 60,p. 243 - 250
[2]Organic and biomolecular chemistry,2003,vol. 1,p. 2427 - 2429

16
[ 7786-61-0 ]
[ 113231-14-4 ]
[ 10083-24-6 ]
[ 33626-09-4 ]
AG 1233 [ No CAS ]

Reference： [1]European Journal of Organic Chemistry,2005,p. 3319 - 3325

17
[ 10083-24-6 ]
[ 3926-62-3 ]
bovine serum albumin [ No CAS ]
[(E)-piceatannol-O-(CH₂C(O)-NH)]14-bovine serum albumin [ No CAS ]

Reference： [1]Analytical Chemistry,2003,vol. 75,p. 6388 - 6393

18
[ 10083-24-6 ]
(E)-3,3',4,5'-tetrahydroxy-β-nitrostilbene [ No CAS ]

Reference： [1]Bioorganic and Medicinal Chemistry Letters,2006,vol. 16,p. 2238 - 2242

19
[ 29884-49-9 ]
[ 10083-24-6 ]

Reference： [1]Life Sciences,1997,vol. 61,p. 2103 - 2110

20
[ 10083-24-6 ]
[ 154-23-4 ]
C₂₈H₂₄O₉ [ No CAS ]

Reference： [1]Journal of Natural Products,2007,vol. 70,p. 1605 - 1610

21
[ 10083-24-6 ]
(+/-)-5-[(1E)-2-[(2R,3R)-2,3-dihydro-3-(4-hydroxy-3,5-dimethoxyphenyl)-2-(hydroxymethyl)-1,4-benzodioxin-7-yl]ethenyl]benzene-1,3-diol [ No CAS ]

Reference： [1]Australian Journal of Chemistry,2007,vol. 60,p. 243 - 250

22
[ 33617-40-2 ]
[ 10083-24-6 ]

Reference： [1]Australian Journal of Chemistry,2007,vol. 60,p. 243 - 250

23
[ 29654-55-5 ]
[ 10083-24-6 ]

Reference： [1]Australian Journal of Chemistry,2007,vol. 60,p. 243 - 250
[2]Justus Liebigs Annalen der Chemie,1971,vol. 750,p. 109 - 127
[3]Bioorganic and Medicinal Chemistry,2011,vol. 19,p. 5085 - 5092

24
[ 104311-39-9 ]
[ 10083-24-6 ]

Reference： [1]Australian Journal of Chemistry,2007,vol. 60,p. 243 - 250
[2]Journal of the Chemical Society. Perkin transactions I,1987,p. 1705 - 1712

25
[ 99815-16-4 ]
[ 10083-24-6 ]

Reference： [1]Australian Journal of Chemistry,2007,vol. 60,p. 243 - 250
[2]Organic and biomolecular chemistry,2003,vol. 1,p. 2427 - 2429

26
[ 29680-76-0 ]
[ 10083-24-6 ]

Reference： [1]Australian Journal of Chemistry,2007,vol. 60,p. 243 - 250
[2]Justus Liebigs Annalen der Chemie,1971,vol. 750,p. 109 - 127

27
(3,5-dihydroxybenzyl)triphenylphosphonium bromide [ No CAS ]
[ 10083-24-6 ]

Reference： [1]Australian Journal of Chemistry,2007,vol. 60,p. 243 - 250

28
[ 139-85-5 ]
[ 10083-24-6 ]

Reference： [1]Australian Journal of Chemistry,2007,vol. 60,p. 243 - 250
[2]Bioorganic and Medicinal Chemistry,2011,vol. 19,p. 5085 - 5092
[3]Patent: KR2017/97422,2017,A

29
C₂₅H₁₉O₂P^(2-)*2Li⁽¹⁺⁾ [ No CAS ]
[ 10083-24-6 ]

Reference： [1]Organic and biomolecular chemistry,2003,vol. 1,p. 2427 - 2429

30
[ 705-76-0 ]
[ 10083-24-6 ]

Reference： [1]Journal of Organic Chemistry,1997,vol. 62,p. 417 - 421

31
[ 185249-90-5 ]
[ 10083-24-6 ]

Reference： [1]Journal of Organic Chemistry,1997,vol. 62,p. 417 - 421

32
[ 185249-83-6 ]
[ 10083-24-6 ]

Reference： [1]Journal of Organic Chemistry,1997,vol. 62,p. 417 - 421

33
[ 5447-02-9 ]
[ 10083-24-6 ]

Reference： [1]Journal of Medicinal Chemistry,1993,vol. 36,p. 2950 - 2955
[2]Patent: KR2017/97422,2017,A

34
[ 2150-44-9 ]
[ 10083-24-6 ]

Reference： [1]Journal of Medicinal Chemistry,1993,vol. 36,p. 2950 - 2955

35
[ 58605-10-0 ]
[ 10083-24-6 ]

Reference： [1]Journal of Medicinal Chemistry,1993,vol. 36,p. 2950 - 2955

36
[ 24131-31-5 ]
[ 10083-24-6 ]

Reference： [1]Journal of Medicinal Chemistry,1993,vol. 36,p. 2950 - 2955
[2]Justus Liebigs Annalen der Chemie,1971,vol. 750,p. 109 - 127
[3]Bioorganic and Medicinal Chemistry,2011,vol. 19,p. 5085 - 5092

37
[ 24131-32-6 ]
[ 10083-24-6 ]

Reference： [1]Journal of Medicinal Chemistry,1993,vol. 36,p. 2950 - 2955
[2]Bioorganic and Medicinal Chemistry,2011,vol. 19,p. 5085 - 5092

38
[ 33617-49-1 ]
[ 10083-24-6 ]

Reference： [1]Journal of Medicinal Chemistry,1993,vol. 36,p. 2950 - 2955

39
[ 94356-28-2 ]
[ 10083-24-6 ]

Reference： [1]Chemical and pharmaceutical bulletin,1984,vol. 32,p. 3501 - 3517

40
[ 116107-19-8 ]
[ 10083-24-6 ]

Reference： [1]Chemical and pharmaceutical bulletin,1988,vol. 36,p. 1545 - 1549

41
[ 504-15-4 ]
[ 10083-24-6 ]

Reference： [1]Journal of the Chemical Society. Perkin transactions I,1987,p. 1705 - 1712

42
[ 10083-24-6 ]
[ 113681-38-2 ]

Reference： [1]Journal of the Chemical Society. Perkin transactions I,1987,p. 1705 - 1712

43
[ 20982-28-9 ]
[ 10083-24-6 ]

Reference： [1]Journal of the Chemical Society. Perkin transactions I,1987,p. 1705 - 1712

44
[ 139-85-5 ]
vegetable indican [ No CAS ]
[ 10083-24-6 ]

Reference： [1]Justus Liebigs Annalen der Chemie,1971,vol. 750,p. 109 - 127

Yield	Reaction Conditions	Operation in experiment
75%	With boron tribromide; In dichloromethane; at 0 - 20℃; for 1h;	General procedure: Dissolve compound 6 (6g, 0.0201mol) in 50ml dichloromethane, add drop wise BBr3 solution in methylene chloride (24ml, 1M) at 0C, react at room temperature for 1h. Wash the reaction solution with water, dry over anhydrous magnesium sulfate. Filter the solution and remove the solvent by rotary evaporation, dissolve the residue with petroleum ether/diethyl ether and feed the solution to a silica gel column, evaporate the soventin eluent to obtain 5.4g white solid (95%). 1H-NMR (400M, CDCl3)delta (ppm): 3.79 (s, 3H), 3.82 (s, 3H), 6.40 (d, J= 2.4Hz, 1H), 6.80 (d, J = 2.4Hz, 1H), 7.15 (dd, J = 16Hz, 2H), 7.28 (t, J = 7.2Hz, 1H), 7.38 (t, J = 7.2Hz, 2H), 7.52 (d, J = 7.2Hz, 2H), 10.28 (s, 1H).
75%	With boron tribromide; In dichloromethane; at 0 - 20℃; for 1h;	General procedure: Example 6 Preparation of methyl 2-hydroxy-4-methoxy-6-[(E)-styryl]benzoate (7) Dissolve compound 6 (6 g, 0.0201 mol) in 50 ml dichloromethane, add drop wise BBr3 solution in methylene chloride (24 ml, 1M) at 0 C., react at room temperature for 1 h. Wash the reaction solution with water, dry over anhydrous magnesium sulfate. Filter the solution and remove the solvent by rotary evaporation, dissolve the residue with petroleum etherdiethyl ether and feed the solution to a silica gel column, evaporate the solvent in eluent to obtain 5.4 g white solid (95%). 1H-NMR (400M, CDCl3) delta (ppm): 3.79 (s, 3H), 3.82 (s, 3H), 6.40 (d, J=2.4 Hz, 1H), 6.80 (d, J=2.4 Hz, 1H), 7.15 (dd, J=16 Hz, 2H), 7.28 (t, J=7.2 Hz, 1H), 7.38 (t, J=7.2 Hz, 2H), 7.52 (d, J=7.2 Hz, 2H), 10.28 (s, 1H).
		, characterized in that the hydroxystilbenes of formula (I) are chosen from the following compounds: ... trans-1-(3'-carboxy-4'-hydroxyphenyl)-2-(2",5"-dihydroxyphenyl)ethane, 3,5-dihydroxy-4'-methoxystilbene 3-O-beta-D-glucoside, trans-3,4',5-trihydroxystilbene, 4',5-dihydroxystilbene 3-O-beta-D-glucoside, 3,3',4,5'-tetrahydroxystilbene, 3,5-dihydroxy-4'-bromostilbene, 2,3,5,4'-tetrahydroxystilbene 2-O-beta-D-glucoside, and 3,5,3'-trihydroxy-4'-methoxystilbene 5-O-beta-D-glucoside;

The regime and/or regimen as defined by claim 2, wherein said at least one hydroxystilbene compound is: ... 2',2,4'-trihydroxystilbene, 2,4,4',5-tetrahydroxystilbene, 2',3,4'5-tetrahydroxystilbene, 2,2',4,4'-tetrahydroxystilbene, 3,3',4',5-tetrahydroxystilbene, 2,3',4,4'-tetrahydroxystilbene, 3,3',4,4'-tetrahydroxystilbene, 3,3',4',5,5'-pentahydroxystilbene, ...

46
[ 250778-33-7 ]
[ 10083-24-6 ]

Reference： [1]Synthetic Communications,2009,vol. 39,p. 1425 - 1432

47
(E)-1-(3-benzyloxy-4-methoxyphenyl)-2-(3,5-dibenzyloxyphenyl)ethylene [ No CAS ]
[ 10083-24-6 ]

Reference： [1]Bulletin of the Korean Chemical Society,2010,vol. 31,p. 971 - 975

48
cis-3,3',4',5-tetramethoxystilbene [ No CAS ]
[ 10083-24-6 ]

Reference： [1]Chemical and Pharmaceutical Bulletin,2010,vol. 58,p. 1492 - 1496

49
[ 5447-02-9 ]
[ 33617-49-1 ]
[ 10083-24-6 ]

Reference： [1]Bioorganic and Medicinal Chemistry,2011,vol. 19,p. 5085 - 5092

50
[ 501-36-0 ]
[ 10083-24-6 ]
[ 26153-38-8 ]
[ 99-10-5 ]
[ 123-08-0 ]

Reference： [1]Rapid Communications in Mass Spectrometry,2010,vol. 24,p. 634 - 642
[2]Biochimie,2012,vol. 94,p. 741 - 747

51
[ 501-36-0 ]
[ 10083-24-6 ]

Yield	Reaction Conditions	Operation in experiment
100%	With streptomyces avermilitis tyrosinase; benzene-1,2-diol; In aq. buffer; for 3h;pH 8.0;Enzymatic reaction;	When cultured according to the above-described expression method 1,The SAV-derived tyrosinase-expressing cells were washed without cell disruption, and then resuspended in 0.1 mM resveratrol,(NADH, L-ascorbic acid, glutathione, cysteine, hydroquinone, 1-naphthol, p-coumaric acid, curcumin, catechol, pyrogallol or ferulic acid)Was added to produce fichethanol.After the reaction, the product was extracted with the same amount of ethylacetate (EA) or nonpolar solvent, and quantitatively analyzed by high performance liquid chromatography to compare the production efficiency of physisathenol by the addition of reducing agent.
100%	With ascorbic acid; In aq. phosphate buffer; dimethyl sulfoxide; at 30℃;pH 6.0;	The reaction was normally carried out in 2.0 mL phosphate buffer(50 mM, pH 6.0) containing 20.0mM Res, 40.0mM L-ascorbic acid and25% (v/v) DMSO (for pre-dissolving Res) in a shaking incubator withagitation of 220 rpm at 30 C. 10.0 mg of tyrosinase CLEAs was added tostart the reaction, and every one hour a 0.1 mL sample was taken,which was then 20 times diluted with 50% (v/v) acetonitrile aqueoussolution before being subjected to HPLC analysis as described below.
	With water; In aq. phosphate buffer; dimethyl sulfoxide; glycerol; at 30℃; for 12h;pH 7.5;	The reaction was performed in a 500-mL flask that contained cells of the transformed E. coli strain (32 g of dry cell weight per liter), resveratrol(30 mM), dimethylsulfoxide (4% v/v), and potassium phosphate buffer (200 mM, pH7.5) containing glycerol (10% v/v) in a volume of 20 mL. The reaction mixture was supplemented with Tween 80 (1% v/v) when required. The reactions were carried out at 30 C with reciprocal shaking at a speed of 240 rpm.

	With Streptomyces sp. strain SB-14; In aq. phosphate buffer; dimethyl sulfoxide; at 28℃; for 24h;pH 7.2;Enzymatic reaction;	The cells harvested from a culture broth of Streptomyces sp. Strain SB-14 were washed twice with apotassium phosphate buffer (50 mM, pH 7.2). After centrifugation (13,000 g, 10 min), 100 mg of cells(wet wt.) was added in 900 muL of a potassium phosphate buffer (100 mM, pH 7.2) with 100 muL ofresveratrol (0.5 mM in DMSO). The total reaction volume was 1 mL and shaken for 24 h at 28 C. After 12 h, the reactant was extracted with ethylacetate (JUNSEI, Kyoto, Japan). The extracted sample was evaporated in a centrifugal vacuum concentrator (BioTron, Puchon, Korea) and dissolved in methanol (MERCK, Darmstadt, Germany).
	With D-glucose 6-phosphate; Bacillus megaterium cytochrome P450 BM3, CYP102A1, wild-type; yeast glucose 6-phosphate; NADP; In aq. phosphate buffer; at 37℃; for 0.166667h;pH 7.4;Enzymatic reaction;Kinetics;	Oxidation of trans-resveratrol, a substrate of human CYP1A2, by CYP102A1 was identified. Typical steady-state reactions for trans-resveratrol hydroxylation included 50 pmol P450 BM3 in 0.25 ml of a 100 mM potassium phosphate buffer (pH 7.4) were performed along with a specified amount of a substrate. To determine the kinetic parameter of several CYP102A1 mutants, 2 to 100 muM of trans-resveratrol was used. An NADPH-generating system was used to initiate reaction solutions (final concentrations: 10 mM glucose 6-phosphate, 0.5 mM NADP+, and 1 IU yeast glucose 6-phosphate per ml). Trans-resveratrol stocks (20 mM) were prepared in DMSO and diluted into the enzyme reactions with the final organic solvent concentration <1% (v/v). Reactions were generally incubated for 10 min at 37 C., and terminated with 105 mul of ice-cold acetic acid/methanol (95/5, v/v).
	With beta-nicotinamide adenine dinucleotide 2?-phosphate reduced tetrasodium salt; ascorbic acid; In aq. phosphate buffer; dimethyl sulfoxide; at 37℃; for 1h;pH 7.4;Darkness; Enzymatic reaction;	Crude protein extracts were prepared from elicited V. vinifera cv. Gamay cell cultures as described in [6]. Resveratrol hydroxylation reaction was assayed as described in [39,53]. The reaction mixture contained 0.2 mM of trans-R delivered in DMSO (Fluka Chemika-Sigma Aldrich, St. Louis, MO, USA),1 mM ascorbic acid, 1 mM NADPH, and 100 mM potassium phosphate buffer, pH 7.4, and started by adding 50 L of protein extract to complete a final volume of 1 mL. The reaction mixture was incubated for 1 h at 37 C in the dark and terminated by the addition of 0.5 mL ethyl acetate to extract stilbenoids twice. The solvent was evaporated in a Speed-vac (Eppendorff, Hamburg, Germany) and the solid residue resuspended in 0.2 mL 80% methanol. One L of reaction medium extract was injected for UHPLC-MS MRM analysis under the optimized conditions. Absolute concentration of stilbenes in real samples of cell extracts and enzymatic reactionextract was determined using an external calibration curve performed with three levels of standards in duplicate.

Reference： [1]Patent: KR101566672,2015,B1 .Location in patent: Paragraph 0077; 0078
[2]Process Biochemistry,2018,vol. 70,p. 90 - 97
[3]ACS Chemical Biology,2012,vol. 7,p. 1687 - 1692
[4]Tetrahedron Letters,2014,vol. 55,p. 2853 - 2855
[5]Molecules,2014,vol. 19,p. 16684 - 16692
[6]Patent: US9109237,2015,B2 .Location in patent: Page/Page column 9; 10
[7]Molecules,2017,vol. 22
[8]Molecules,2019,vol. 24

53
[ 10083-24-6 ]
[ 7400-08-0 ]
C₂₂H₂₀O₅ [ No CAS ]

Yield	Reaction Conditions	Operation in experiment
90 mg	In ethanol; water; at 130℃; for 1.5h;pH 5.0;Autoclave;	500 mg of piceatannol (manufactured by Tokyo Chemical Industry Co., Ltd.) and 500mg of p-coumaric acid were dissolved in 10 mL of ethanol, and then 10 mL of mineral water was added, thereby obtaining a solution (pH=5.0) containing piceatannol and p-coumaric acid. The solution containing piceatannol and p-coumaric acid was heated at130 C. for 90 minutes in an autoclave. 1 mL of the obtained reactant solution was diluted with methanol in a measuring cylinder to 50 mL, and then analyzed by HPLC in the same manner as in Example 1. The obtained chromatograms are shown in FIG. 6. The upper view shows the chromatogram before the generation reaction and the lower view shows the chromatogram afier the generation reaction. As shown in the lower view, it was confirmed that a plurality of compounds are generated including the peak I.

Reference： [1]Patent: US2013/296613,2013,A1 .Location in patent: Paragraph 0146-0157

54
[ 108957-73-9 ]
[ 10083-24-6 ]

Yield	Reaction Conditions	Operation in experiment
53.93%	With pyridine hydrochloride; at 240℃; for 1h;	Preheat the 50ml round bottom flask to 100 C. Then add pyridine hydrochloride (5 g, 43.27 mmol), heat to 180 C, after its pyridine hydrochloride is dissolved, Further, E-3-hydroxy-3',4,5'-trimethoxystilbene (0.2 g, 0.70 mmol) was added, and the temperature was further raised to 240 C. After 1 h, the reaction was completed by TLC. Cool to room temperature and add 30 mL of water. Extract with ethyl acetate (50 mL × 3), and combine the organic phases. Wash with saturated brine (100 mL × 3), and finally dry with anhydrous sodium sulfate. The filtrate was spun dry under reduced pressure at 50 C to obtain 230 mg of dark black oil. Column chromatography (methanol: dichloromethane = 1:20, 1.5 L)Purification gave 92 mg of a gray solid, yield 53.93%.

Reference： [1]Patent: CN108675918,2018,A .Location in patent: Paragraph 0011; 0025; 0030; 0031

55
[ 58-08-2 ]
[ 10083-24-6 ]
1,3,7-trimethyl-1H-purine-2,6(3H,7H)-dione piceatannol cocrystal [ No CAS ]

Yield	Reaction Conditions	Operation in experiment
	In ethanol; at 25 - 35℃; for 5h;	Piceatannol (3.77 g) was dissolved in ethanol (36 ml) at 25-35C. To this solution, caffeine (3 g) was added and slurried for 5 hrs at 25-35C. The solid obtained was filtered and suck dried to get caffeine: piceatannol (3:2) cocrystal Form I. HPLC: Caffeine: 38.91% & piceatannol: 60.83% The XRPD is set forth in 7; The DSC is set forth in Figure 8; The TGA is set forth in Figure 9.

Reference： [1]Patent: WO2017/9813,2017,A1 .Location in patent: Page/Page column 20

56
[ 10083-24-6 ]
(Z)-3,5,3',4'-tetrahydroxystilbene [ No CAS ]

Yield	Reaction Conditions	Operation in experiment
	In methanol; acetonitrile;UV-irradiation;	General procedure: Stock solutions of each individual standard stilbene were prepared in 80% methanol, resveratrol (500 mg/L), piceid (400 mg/mL), piceatannol (160 mg/mL), epsilon-viniferin (800 mg/mL), and pterostilbene (400 mg/mL). These stock solutions were used to prepare a mixture containing the following concentration of standards: resveratrol (50 mg/L), piceid (40 mg/mL), piceatannol (90 mg/mL), epsilon-viniferin (90 mg/mL), and pterostilbene (40 mg/mL). Dilutions of either pure of mixed standards were carried out in 80% methanol. To generate cis-isomers of the standards, the stilbene mixture was exposed to UV light using a germicide lamp for 3 h (short exposition) or 24 h (prolonged exposition).

Reference： [1]Molecules,2017,vol. 22

57
C₂₀H₂₀O₆ [ No CAS ]
[ 10083-24-6 ]

Yield	Reaction Conditions	Operation in experiment
	With boron tribromide; In dichloromethane; at 20℃; for 2.5h;Inert atmosphere; Cooling with ice;	General procedure: Acetic acid 4-[2-(3,5-dibromo-4-methoxy-phenyl)-vinyl]-phenyl ester (33 mg, 0.077 mmol) was diluted in dichloromethane (1.0 mL) and added 1.0 M dichloromethane solution of boron tribromide (0.23 mL, 0.23 mmol) under nitrogen and ice cooling. The mixture was stirred at room temperature for 2.5 h. The reaction mixture was added to cooled water under ice cooling, and extracted with ethyl acetate. The combined organic layer was washed with water and brine, then dried over anhydrous MgSO4, filtered and concentrated under reduced pressure. The resulting residue was purified by silica gel column chromatography (20% ethyl acetate in n-hexane) to give the desire compound 4z as a white powder (26 mg, 91%).

Reference： [1]Bioorganic and Medicinal Chemistry Letters,2017,vol. 27,p. 3167 - 3172

58
[ 39192-49-9 ]
[ 10083-24-6 ]

Reference： [1]Bioorganic and Medicinal Chemistry Letters,2017,vol. 27,p. 3167 - 3172

59
[ 6380-23-0 ]
[ 10083-24-6 ]

Reference： [1]Bioorganic and Medicinal Chemistry Letters,2017,vol. 27,p. 3167 - 3172

60
[ 10083-24-6 ]
2,4-dichloro-6-{4-[4-(1,2,2-triphenylethenyl)phenyl]-1H-1,2,3-triazol-1-yl}-1,3,5-triazine [ No CAS ]
C₄₅H₃₁ClN₆O₄ [ No CAS ]

Yield	Reaction Conditions	Operation in experiment
	With potassium carbonate; In methanol; at 40℃; for 7h;	In a 50 ml reaction vessel, 1 mol of paclitaxel, 1.5 mol of potassium carbonate, 1 mol of fluorescent label III and2 moles of methanol, and the temperature was controlled at 40 C for 7 h. After completion of the reaction, after the completion of the reaction, the reaction solvent was dried and the mixture was post-treated To get the product.

Reference： [1]Patent: CN106967049,2017,A .Location in patent: Paragraph 0040; 0041; 0042

61
[ 10083-24-6 ]
[ 572-09-8 ]
C₂₀H₂₂O₉ [ No CAS ]

Yield	Reaction Conditions	Operation in experiment
	With zeolite A; potassium hydroxide; In ethanol; for 24h;Molecular sieve; Darkness;	Piceatannol, TAGluB and potassium hydroxide were dissolved in 2 mL of dry ethanol at a molar ratio of 1: 1: 2 (At this time, the total amount of the three is 105 mg),To this 5 mg of molecular sieve 4A was added, which is an amount sufficient to remove water molecules generated in the reaction system, and reacted for 24 hours under light shielding. The reaction product thus obtained was dissolved in distilled water and partitioned and extracted with ethyl acetate, and the aqueous phase fraction was further subjected to partitioning extraction with n-butanol. The ethyl acetate fraction obtained here was subjected to HPLC.

Reference： [1]Patent: JP2018/127441,2018,A .Location in patent: Paragraph 0088-0089

62
[ 621-59-0 ]
[ 10083-24-6 ]

Reference： [1]Patent: CN108675918,2018,A

63
[ 10083-24-6 ]
[ 74-88-4 ]
[ 32507-66-7 ]
(E)-5-[2-(3,4-dimethoxyphenyl)vinyl]benzene-1,3-diol [ No CAS ]
[ 500-65-2 ]
3,4,5′-trihydroxy-3′-methoxy-trans-stilbene [ No CAS ]

Yield	Reaction Conditions	Operation in experiment
8.1%; 1%; 12.9%; 1.4%	With sodium acetate; In N,N-dimethyl-formamide; at 100℃; for 0.0833333h;	trans- piceatannol (131.9 mg, 0.54 mmol)Solution in DMF (1.8 mL)Sodium acetate (177.2 mg, 2.16 mmol, 4.0 equivalents) and methyl iodide (260.6 muL, 4.32 mmol, 8.0 equivalents) were added and stirred at 100 C. for 5 minutes. after that,Separation and purification by ODS-HPLC,Unreacted <strong>[10083-24-6]trans-piceatannol</strong> 85.5 mg (recovery: 64.8%) is obtained at a retention time of 24.7 minutes,In a retention time of 42.9 minutes, 11.3 mg (yield: 8.1%) of trans-3Me-piceatannol represented by the structural formula at the upper left is obtained.In a retention time of 45.1 minutes, 18.0 mg (yield: 12.9%) of trans-4Me-piceatannol represented by the structural formula on the upper right is obtained,In a retention time of 51.7 minutes, 2.0 mg (yield: 1.4%) of trans-3'Me-piceatannol represented by the following structural formula at the lower left,And 1.5 mg of trans-3,4 diMe- piceatannol represented by the following structural formula at the holding time of 54.6 minutes. 1.5mg(Yield: 1.0%) was obtained.

Reference： [1]Patent: JP5873318,2016,B2 .Location in patent: Paragraph 0040; 0052; 0053; 0054; 0055

64
[ 10083-24-6 ]
[ 107-02-8 ]
C₁₇H₁₆O₅ [ No CAS ]
C₂₀H₂₀O₆ [ No CAS ]

Yield	Reaction Conditions	Operation in experiment
	In aq. phosphate buffer; at 37℃; for 4h;pH 7.4;	General procedure: Resveratrol, oxyresveratrol, and piceatannol (300 mg each) were respectively incubated with acrolein or methylglyoxal (200 mul each) in a pH 7.4 phosphate buffer solution (300 ml) at 37 C for 4 h. Each reaction solution was partitioned by ethyl acetate. Each ethyl acetate extraction was evaporated in a rotary evaporator at no more than 40 C. Then, for the separation of acrolein adducts, in general, the crude ethyl acetate extractions were loaded onto silica gel and eluted by a dichloromethane and methanol gradient (25:1, 19:1, 9:1, 4:1). The fractions among 9:1 to 4:1 were collected, combined and loaded on a Sephadex LH-20 column, and then eluted using methanol to obtain pure adducts 1, 3, 4, 5, and 8 respectively. The combination and purity of these adducts were checked by TLC plates visualized under UV light at 254 nm. For the methylglyoxal adducts, in general, the crude ethyl acetate extractions were chromatographed over C18 column and eluted using a methanol and water gradient (4:6, 5:5, 6:4, pure methanol). The fractions collected among 5:5 to 6:4 were combined and further purified using Sephadex LH-20 column eluted with methanol to yield pure adducts 2, 6, and 7, respectively. Similarly, the combination and purity were also determined by TLC plates visualized under UV light at 254 nm.

Reference： [1]Food Chemistry,2019,vol. 295,p. 10 - 15

65
[ 10083-24-6 ]
[ 78-98-8 ]
C₁₇H₁₆O₆ [ No CAS ]

Yield	Reaction Conditions	Operation in experiment
	In aq. phosphate buffer; at 37℃; for 4h;pH 7.4;	General procedure: Resveratrol, oxyresveratrol, and piceatannol (300 mg each) were respectively incubated with acrolein or methylglyoxal (200 mul each) in a pH 7.4 phosphate buffer solution (300 ml) at 37 C for 4 h. Each reaction solution was partitioned by ethyl acetate. Each ethyl acetate extraction was evaporated in a rotary evaporator at no more than 40 C. Then, for the separation of acrolein adducts, in general, the crude ethyl acetate extractions were loaded onto silica gel and eluted by a dichloromethane and methanol gradient (25:1, 19:1, 9:1, 4:1). The fractions among 9:1 to 4:1 were collected, combined and loaded on a Sephadex LH-20 column, and then eluted using methanol to obtain pure adducts 1, 3, 4, 5, and 8 respectively. The combination and purity of these adducts were checked by TLC plates visualized under UV light at 254 nm. For the methylglyoxal adducts, in general, the crude ethyl acetate extractions were chromatographed over C18 column and eluted using a methanol and water gradient (4:6, 5:5, 6:4, pure methanol). The fractions collected among 5:5 to 6:4 were combined and further purified using Sephadex LH-20 column eluted with methanol to yield pure adducts 2, 6, and 7, respectively. Similarly, the combination and purity were also determined by TLC plates visualized under UV light at 254 nm.

Reference： [1]Food Chemistry,2019,vol. 295,p. 10 - 15

66
[ 5447-02-9 ]
[ 67093-27-0 ]
[ 10083-24-6 ]

Reference： [1]Patent: CN109970517,2019,A

67
C₄₂H₃₆O₅ [ No CAS ]
[ 10083-24-6 ]

Yield	Reaction Conditions	Operation in experiment
41.2 g	With hydrogen; at 25 - 100℃; for 12h;	67.7 g of 3,5-dibenzyloxybenzyl chloride,63.6 g of 3,4-dibenzyloxybenzaldehyde, 6.36 g of 10 wt%Palladium carbon catalystMix with 400 g of ethyl acetate.After heating to 80 C for 9 hours,Cooling the obtained reaction solution to below 25 C;The gas in the reaction vessel was replaced with hydrogen gas, and then hydrogen gas was introduced to a pressure of 2 kg·f/cm 2 , and then the temperature was raised to 100 C., and the reaction was continued for 12 hours. The obtained reaction liquid was filtered to recover a catalyst, and the filtrate was evaporated to dryness. Dissolve with 50 g of toluene to 80 C, then cool to 10 C and filter dry.41.2 g of paclitaxel was obtained in a yield of 84.4% using liquid chromatographyThe test purity was 99.5%.

Reference： [1]Patent: CN109970517,2019,A .Location in patent: Paragraph 0064; 0065

68
[ 108957-72-8 ]
[ 10083-24-6 ]

Yield	Reaction Conditions	Operation in experiment
62%	With boron tribromide; In dichloromethane; at 0 - 20℃;	To a solution of 6 (1mmol) in CH2Cl2 (4mL), was added dropwise 1mL of BBr3 (solution 1M in CH2Cl2) at temperature of 0C. The reaction mixture was stirred at room temperature over night and after was quenched by addition of 4mL of water at 0C. The resulting mixture was stirred for 30min at 0C. The aqueous layer was extracted with ethyl acetate and the organic extracts were combined, washed with brine, dried over Na2SO4 and concentrated by rotary evaporation. The crude product was purified by flash chromatography on silica gel using hexane/ethyl acetate (from 7:3 to 6:4) as eluent to obtain 62% of compound 2.1H NMR data are in agreement with those reported in literature [35-37].

Reference： [1]European Journal of Medicinal Chemistry,2019,vol. 180,p. 637 - 647

69
[ 537-42-8 ]
[ 10083-24-6 ]

Reference： [1]Molecules,2019,vol. 24

70
(trans)-4-[2-(3,5-dimethoxyphenyl)ethenyl]-1,2-benzenediol [ No CAS ]
[ 10083-24-6 ]

Reference： [1]Molecules,2019,vol. 24

71
C₁₆H₁₄O₄ [ No CAS ]
[ 10083-24-6 ]

Reference： [1]Molecules,2019,vol. 24

72
[ 42206-94-0 ]
[ 10083-24-6 ]

Reference： [1]Molecules,2019,vol. 24

73
[ 122616-63-1 ]
[ 10083-24-6 ]

Reference： [1]Molecules,2019,vol. 24

Same Skeleton Products

Related Products

Historical Records

Ghs Precautionary Statements

Precautionary Statements-General
Code	Phrase
P101	If medical advice is needed,have product container or label at hand.
P102	Keep out of reach of children.
P103	Read label before use
Prevention
Code	Phrase
P201	Obtain special instructions before use.
P202	Do not handle until all safety precautions have been read and understood.
P210	Keep away from heat/sparks/open flames/hot surfaces. - No smoking.
P211	Do not spray on an open flame or other ignition source.
P220	Keep/Store away from clothing/combustible materials.
P221	Take any precaution to avoid mixing with combustibles
P222	Do not allow contact with air.
P223	Keep away from any possible contact with water, because of violent reaction and possible flash fire.
P230	Keep wetted
P231	Handle under inert gas.
P232	Protect from moisture.
P233	Keep container tightly closed.
P234	Keep only in original container.
P235	Keep cool
P240	Ground/bond container and receiving equipment.
P241	Use explosion-proof electrical/ventilating/lighting/equipment.
P242	Use only non-sparking tools.
P243	Take precautionary measures against static discharge.
P244	Keep reduction valves free from grease and oil.
P250	Do not subject to grinding/shock/friction.
P251	Pressurized container: Do not pierce or burn, even after use.
P260	Do not breathe dust/fume/gas/mist/vapours/spray.
P261	Avoid breathing dust/fume/gas/mist/vapours/spray.
P262	Do not get in eyes, on skin, or on clothing.
P263	Avoid contact during pregnancy/while nursing.
P264	Wash hands thoroughly after handling.
P265	Wash skin thouroughly after handling.
P270	Do not eat, drink or smoke when using this product.
P271	Use only outdoors or in a well-ventilated area.
P272	Contaminated work clothing should not be allowed out of the workplace.
P273	Avoid release to the environment.
P280	Wear protective gloves/protective clothing/eye protection/face protection.
P281	Use personal protective equipment as required.
P282	Wear cold insulating gloves/face shield/eye protection.
P283	Wear fire/flame resistant/retardant clothing.
P284	Wear respiratory protection.
P285	In case of inadequate ventilation wear respiratory protection.
P231 + P232	Handle under inert gas. Protect from moisture.
P235 + P410	Keep cool. Protect from sunlight.
Response
Code	Phrase
P301	IF SWALLOWED:
P304	IF INHALED:
P305	IF IN EYES:
P306	IF ON CLOTHING:
P307	IF exposed:
P308	IF exposed or concerned:
P309	IF exposed or if you feel unwell:
P310	Immediately call a POISON CENTER or doctor/physician.
P311	Call a POISON CENTER or doctor/physician.
P312	Call a POISON CENTER or doctor/physician if you feel unwell.
P313	Get medical advice/attention.
P314	Get medical advice/attention if you feel unwell.
P315	Get immediate medical advice/attention.
P320
P302 + P352	IF ON SKIN: wash with plenty of soap and water.
P321
P322
P330	Rinse mouth.
P331	Do NOT induce vomiting.
P332	IF SKIN irritation occurs:
P333	If skin irritation or rash occurs:
P334	Immerse in cool water/wrap n wet bandages.
P335	Brush off loose particles from skin.
P336	Thaw frosted parts with lukewarm water. Do not rub affected area.
P337	If eye irritation persists:
P338	Remove contact lenses, if present and easy to do. Continue rinsing.
P340	Remove victim to fresh air and keep at rest in a position comfortable for breathing.
P341	If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.
P342	If experiencing respiratory symptoms:
P350	Gently wash with plenty of soap and water.
P351	Rinse cautiously with water for several minutes.
P352	Wash with plenty of soap and water.
P353	Rinse skin with water/shower.
P360	Rinse immediately contaminated clothing and skin with plenty of water before removing clothes.
P361	Remove/Take off immediately all contaminated clothing.
P362	Take off contaminated clothing and wash before reuse.
P363	Wash contaminated clothing before reuse.
P370	In case of fire:
P371	In case of major fire and large quantities:
P372	Explosion risk in case of fire.
P373	DO NOT fight fire when fire reaches explosives.
P374	Fight fire with normal precautions from a reasonable distance.
P376	Stop leak if safe to do so. Oxidising gases (section 2.4) 1
P377	Leaking gas fire: Do not extinguish, unless leak can be stopped safely.
P378
P380	Evacuate area.
P381	Eliminate all ignition sources if safe to do so.
P390	Absorb spillage to prevent material damage.
P391	Collect spillage. Hazardous to the aquatic environment
P301 + P310	IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician.
P301 + P312	IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell.
P301 + P330 + P331	IF SWALLOWED: Rinse mouth. Do NOT induce vomiting.
P302 + P334	IF ON SKIN: Immerse in cool water/wrap in wet bandages.
P302 + P350	IF ON SKIN: Gently wash with plenty of soap and water.
P303 + P361 + P353	IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower.
P304 + P312	IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell.
P304 + P340	IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing.
P304 + P341	IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.
P305 + P351 + P338	IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
P306 + P360	IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes.
P307 + P311	IF exposed: call a POISON CENTER or doctor/physician.
P308 + P313	IF exposed or concerned: Get medical advice/attention.
P309 + P311	IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician.
P332 + P313	IF SKIN irritation occurs: Get medical advice/attention.
P333 + P313	IF SKIN irritation or rash occurs: Get medical advice/attention.
P335 + P334	Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages.
P337 + P313	IF eye irritation persists: Get medical advice/attention.
P342 + P311	IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician.
P370 + P376	In case of fire: Stop leak if safe to Do so.
P370 + P378	In case of fire:
P370 + P380	In case of fire: Evacuate area.
P370 + P380 + P375	In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion.
P371 + P380 + P375	In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion.
Storage
Code	Phrase
P401
P402	Store in a dry place.
P403	Store in a well-ventilated place.
P404	Store in a closed container.
P405	Store locked up.
P406	Store in corrosive resistant/ container with a resistant inner liner.
P407	Maintain air gap between stacks/pallets.
P410	Protect from sunlight.
P411
P412	Do not expose to temperatures exceeding 50 oC/ 122 oF.
P413
P420	Store away from other materials.
P422
P402 + P404	Store in a dry place. Store in a closed container.
P403 + P233	Store in a well-ventilated place. Keep container tightly closed.
P403 + P235	Store in a well-ventilated place. Keep cool.
P410 + P403	Protect from sunlight. Store in a well-ventilated place.
P410 + P412	Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF.
P411 + P235	Keep cool.
Disposal
Code	Phrase
P501	Dispose of contents/container to ...
P502	Refer to manufacturer/supplier for information on recovery/recycling

Purity	Size	Price	VIP Price	USA Stock *0-1 Day	Global Stock *5-7 Days	Quantity
{[ item.p_purity ]}	{[ item.pr_size ]}	{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]}	{[ getRatePrice(item.pr_usd, 1,1) ]}	Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]}	{[ item.pr_usastock ]}	Inquiry -	{[ item.pr_chinastock ]}	Inquiry -

Physical hazards
Code	Phrase
H200	Unstable explosive
H201	Explosive; mass explosion hazard
H202	Explosive; severe projection hazard
H203	Explosive; fire, blast or projection hazard
H204	Fire or projection hazard
H205	May mass explode in fire
H220	Extremely flammable gas
H221	Flammable gas
H222	Extremely flammable aerosol
H223	Flammable aerosol
H224	Extremely flammable liquid and vapour
H225	Highly flammable liquid and vapour
H226	Flammable liquid and vapour
H227	Combustible liquid
H228	Flammable solid
H229	Pressurized container: may burst if heated
H230	May react explosively even in the absence of air
H231	May react explosively even in the absence of air at elevated pressure and/or temperature
H240	Heating may cause an explosion
H241	Heating may cause a fire or explosion
H242	Heating may cause a fire
H250	Catches fire spontaneously if exposed to air
H251	Self-heating; may catch fire
H252	Self-heating in large quantities; may catch fire
H260	In contact with water releases flammable gases which may ignite spontaneously
H261	In contact with water releases flammable gas
H270	May cause or intensify fire; oxidizer
H271	May cause fire or explosion; strong oxidizer
H272	May intensify fire; oxidizer
H280	Contains gas under pressure; may explode if heated
H281	Contains refrigerated gas; may cause cryogenic burns or injury
H290	May be corrosive to metals
Health hazards
Code	Phrase
H300	Fatal if swallowed
H301	Toxic if swallowed
H302	Harmful if swallowed
H303	May be harmful if swallowed
H304	May be fatal if swallowed and enters airways
H305	May be harmful if swallowed and enters airways
H310	Fatal in contact with skin
H311	Toxic in contact with skin
H312	Harmful in contact with skin
H313	May be harmful in contact with skin
H314	Causes severe skin burns and eye damage
H315	Causes skin irritation
H316	Causes mild skin irritation
H317	May cause an allergic skin reaction
H318	Causes serious eye damage
H319	Causes serious eye irritation
H320	Causes eye irritation
H330	Fatal if inhaled
H331	Toxic if inhaled
H332	Harmful if inhaled
H333	May be harmful if inhaled
H334	May cause allergy or asthma symptoms or breathing difficulties if inhaled
H335	May cause respiratory irritation
H336	May cause drowsiness or dizziness
H340	May cause genetic defects
H341	Suspected of causing genetic defects
H350	May cause cancer
H351	Suspected of causing cancer
H360	May damage fertility or the unborn child
H361	Suspected of damaging fertility or the unborn child
H361d	Suspected of damaging the unborn child
H362	May cause harm to breast-fed children
H370	Causes damage to organs
H371	May cause damage to organs
H372	Causes damage to organs through prolonged or repeated exposure
H373	May cause damage to organs through prolonged or repeated exposure
Environmental hazards
Code	Phrase
H400	Very toxic to aquatic life
H401	Toxic to aquatic life
H402	Harmful to aquatic life
H410	Very toxic to aquatic life with long-lasting effects
H411	Toxic to aquatic life with long-lasting effects
H412	Harmful to aquatic life with long-lasting effects
H413	May cause long-lasting harmful effects to aquatic life
H420	Harms public health and the environment by destroying ozone in the upper atmosphere

[ CAS No. 10083-24-6 ] {[proInfo.proName]}

Quality Control of [ 10083-24-6 ]

Related Doc. of [ 10083-24-6 ]

Product Details of [ 10083-24-6 ]

Calculated chemistry of [ 10083-24-6 ]

Physicochemical Properties

Pharmacokinetics

Lipophilicity

Druglikeness

Water Solubility

Medicinal Chemistry

Safety of [ 10083-24-6 ]

Application In Synthesis of [ 10083-24-6 ]

[ 10083-24-6 ] Synthesis Path-Upstream 1~1

[ 10083-24-6 ] Synthesis Path-Downstream 1~73

Precautionary Statements-General

Prevention

Response

Storage

Disposal

Physical hazards

Health hazards

Environmental hazards

Inquiry